Researcher from University of Leuven (KU Leuven) Reports Details of New Studies and Findings in the Area of Herpes Simplex Virus 1 (Combination of ganciclovir and trifluridine prevents drug-resistance emergence in HSV-1).

Předmět:	HERPES simplex virus GANCICLOVIR RESEARCH personnel HERPESVIRUS diseases VIRUS diseases
Zdroj:	Drug Week; 5/3/2024, p2057-2057, 1p
Abstrakt:	A recent report from the University of Leuven discusses the findings of a study on herpes simplex virus 1 (HSV-1). The study focused on the development of drug resistance in HSV-1 infections and the potential for novel therapies. The researchers found that a combination of ganciclovir and trifluridine prevented the emergence of drug resistance in HSV-1. They identified specific mutations that confer resistance to nucleoside analogs and suggested that combination therapy with ganciclovir and trifluridine could be an effective strategy to prevent drug resistance. This research provides valuable insights into the treatment of HSV-1 infections and the development of new therapies. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu